These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26190207)

  • 1. Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays.
    Liu JY; Chen XE; Zhang YL
    Sci Rep; 2015 Jul; 5():12359. PubMed ID: 26190207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg
    Assis LC; de Castro AA; Prandi IG; Mancini DT; de Giacoppo JOS; Savedra RML; de Assis TM; Carregal JB; da Cunha EFF; Ramalho TC
    J Mol Model; 2018 Oct; 24(10):303. PubMed ID: 30280322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
    Chattopadhyay D; Swingle MR; Salter EA; Wood E; D'Arcy B; Zivanov C; Abney K; Musiyenko A; Rusin SF; Kettenbach A; Yet L; Schroeder CE; Golden JE; Dunham WH; Gingras AC; Banerjee S; Forbes D; Wierzbicki A; Honkanen RE
    Biochem Pharmacol; 2016 Jun; 109():14-26. PubMed ID: 27002182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
    Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
    J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
    Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
    J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism.
    Hong TJ; Park K; Choi EW; Hahn JS
    Biochem Biophys Res Commun; 2017 Jan; 482(2):215-220. PubMed ID: 27840051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
    Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
    Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cantharidin impedes the activity of protein serine/threonine phosphatase in Plutella xylostella.
    Chen X; Liu J; Zhang Y
    Mol Biosyst; 2014 Feb; 10(2):240-50. PubMed ID: 24253262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of new drug-like inhibitors for serine/threonine protein phosphatase 5 of Plasmodium falciparum: a docking and simulation study.
    Gupta S; Jadaun A; Kumar H; Raj U; Varadwaj PK; Rao AR
    J Biomol Struct Dyn; 2015; 33(11):2421-41. PubMed ID: 25967133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
    McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
    Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).
    Swingle MR; Honkanen RE
    Assay Drug Dev Technol; 2014 Oct; 12(8):481-96. PubMed ID: 25383722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.
    Ren Y; Kinghorn AD
    Bioorg Med Chem; 2021 Feb; 32():116012. PubMed ID: 33454654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.
    Baba Y; Hirukawa N; Sodeoka M
    Bioorg Med Chem; 2005 Sep; 13(17):5164-70. PubMed ID: 15951185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and biochemical characterization of protein phosphatase 5 from the cantharidin-producing blister beetle, Epicauta chinensis.
    Chen X; Lü S; Zhang Y
    Int J Mol Sci; 2013 Dec; 14(12):24501-13. PubMed ID: 24351830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and dynamic simulation evaluation of Rohinitib - Cantharidin based novel HSF1 inhibitors for cancer therapy.
    Agarwal T; Annamalai N; Khursheed A; Maiti TK; Arsad HB; Siddiqui MH
    J Mol Graph Model; 2015 Sep; 61():141-9. PubMed ID: 26245696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin).
    Baba Y; Hirukawa N; Tanohira N; Sodeoka M
    J Am Chem Soc; 2003 Aug; 125(32):9740-9. PubMed ID: 12904040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of protein phosphatase 5 from three lepidopteran insects: Helicoverpa armigera, Mythimna separata and Plutella xylostella.
    Chen X; Lü S; Zhang Y
    PLoS One; 2014; 9(5):e97437. PubMed ID: 24823652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
    McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?
    McCuskey A; Keane MA; Mudgee LM; Sim AT; Sakoff J; Quinn RJ
    Eur J Med Chem; 2000 Oct; 35(10):957-64. PubMed ID: 11121622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activators of protein phosphatase 5 target the auto-inhibitory mechanism.
    Haslbeck V; Drazic A; Eckl JM; Alte F; Helmuth M; Popowicz G; Schmidt W; Braun F; Weiwad M; Fischer G; Gemmecker G; Sattler M; Striggow F; Groll M; Richter K
    Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.